Our Featured Experts

Fred Saad, MD
Dr. Saad on Results of Radium-223 Trial in Prostate Cancer
Fred Saad, MD, professor and chief of Urology, director of Genitourinary Oncology at the University of Montreal Hospital Centers, discusses results of a trial that investigated early use of radium-223 dichloride (Xofigo) in patients with asymptomatic metastatic castration-resistant prostate cancer.
Jacqueline C. Barrientos, MD
Dr. Barrientos Discusses Acalabrutinib in CLL
Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses the role of acalabrutinib (Calquence) for patients with chronic lymphocytic leukemia (CLL).
Oncology Specialists
Publication Bottom Border
Border Publication